He tested negative for driver gene mutations, and PD-L1 negative (<1%), but a high tumor mutational burden (30.9 and 39.1 mutations/Mb in the lung tissue and blood, respectively), and positive tumor-infiltrating lymphocytes. Here, CD274 is linked to neoplasm.